NCT06931717 2026-03-18
ARCH
ETOP IBCSG Partners Foundation
Phase 3 Recruiting
Clinical Trials
7 trialsNCT06284317 2026-03-16
ADOPT-lung
ETOP IBCSG Partners Foundation
Phase 3 Recruiting
NCT04093167 2026-03-11
Study of CTDNA Response Adaptive Immuno-Chemotherapy in Lung Cancer
Canadian Cancer Trials Group
Phase 2/3 Recruiting
NCT06686771 2026-03-05
CURB2
Canadian Cancer Trials Group
Phase 3 Recruiting
NCT03057106 2026-03-03
Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLC
Canadian Cancer Trials Group
Phase 2 Active not recruiting
NCT03804255 2026-03-02
Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting
Eastern Cooperative Oncology Group
Withdrawn
NCT06219317 2026-02-23
ICARS
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Recruiting